This inventor holds 6 USPTO granted patents and 2 published patent applications. Top assignees: Sutter Bay Hospitals, Sutter West Bay Hospitals. Active years: 2015-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Daly City, CA (US) (2016)
- San Francisco, CA (US) (2015 - 2022)
Company Filing History:
Years Active: 2015-2022
Title: The Innovative Contributions of Sean D McAllister
Introduction
Sean D McAllister is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 6 patents to his name, McAllister is recognized for his work in creating methods and compositions that address cell proliferative disorders, including cancer.
Latest Patents
Among his latest patents, McAllister has developed methods and compositions for treating cancer. This disclosure provides compositions and methods useful for treating cell proliferative disorders, including cancer. The disclosure includes cannabidiol derivatives and compositions that can be used either alone or in combination with THC or a derivative thereof. His work in this area is paving the way for new therapeutic approaches to combat cancer.
Career Highlights
Throughout his career, McAllister has worked with notable institutions such as Sutter West Bay Hospitals and Sutter Bay Hospitals. His experience in these organizations has allowed him to collaborate with other experts in the field and further his research endeavors.
Collaborations
Some of his notable coworkers include Pierre-Yves Desprez and Anuradha Mahadevan. Their collaborative efforts have contributed to the advancement of cancer treatment methodologies.
Conclusion
Sean D McAllister's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. His contributions continue to inspire advancements in therapeutic solutions for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile